Cardiogen
Heart
Heart bioregulator — gene level support for cardiac tissue.
A peptide bioregulator targeting myocardial cells. Used in Russian cardiology as adjunctive support for aging hearts and recovery from cardiac events.
- Cardiovascular aging
- Recovery after cardiac events
- Family history of heart disease
Educational only · Not a vendor claim
Peptide bioregulator targeting myocardial gene expression for cardiac maintenance.
- Cardiovascular aging support
- Recovery after cardiac events
- Genetic risk hedging
- Subjective stamina improvement
- Better exercise tolerance
- Tissue targeted action
- Safe pulsed dosing
- Decades of Russian use
- Subtle effects
- Limited large trials
- Rare injection site irritation
Educational summary · Not medical advice · Discuss with a qualified clinician
Typical timeline
General pattern for the Bioregulator category. Individual response varies.
- Days 1–10No acute effects. This class works at the gene expression level — subtle by design.
- Days 10–20Organ-specific improvements accumulate. Bloodwork often reflects the change more than symptoms do.
- Post-cycleBenefits persist 2–4 months. Standard cadence is 20–30 days on, then a 2-month break, 2–3 cycles per year.
The reconstitution math
- 1Reconstitute the 20 mg vial with 2 mL of bacteriostatic water. Tilt — don't shake.
- 2Concentration becomes 10,000 mcg/mL (10 mg/mL).
- 3For a 2 mg dose, draw 0.200 mL — that's 20 units on a 1 mL insulin syringe.
- 4One vial gives you approximately 10 doses.
Reminder: 100 units on an insulin syringe = 1 mL. Always start at half the listed dose for the first week and rotate injection sites between arms, legs, abdomen, and glutes.
Sign in to keep a private log of your doses and notes for Cardiogen.
Use code ANYPEPTIDES15 for 15% off your order.
Discount may end or change without notice.